SUMMARY The reliability of immunological identification of Neisseria gonorrhoeae using polyclonal and monoclonal antibody coagglutination reagents has been evaluated. When clinical isolates of neisseriae were tested in an "in-use" trial the sensitivity and specificity of each reagent were similar and the overall agreement with carbohydrate utilisation was 97 9% (141/144) for the polyclonal antibody reagent and 97*2% (140/144) for the monoclonal reagent. When results of testing 13 stock cultures of N lactamica and five stock cultures of f3-lactamase producing Branhamella catarrhalis were combined with the results for clinical isolates of non-gonococcal neisseriae the agreement with carbohydrate utilisation was 86*5% (64/74) for the polyclonal reagent and 97*3% (72/74) for the monoclonal reagent: this difference is statistically significant at the 5% level.
Gonorrhoea remains a prevalent infection; 55 784
cases were identified and treated in clinics in England during the year ending 30 June 1980 .' Because of the heavy microbiological workload this imposes there is a considerable incentive to develop and implement simple, rapid, and reliable methods of differentiating between gonococcal and nongonococcal neisseriae. The development of the coagglutination reaction2 increased the popularity of immunological identification of Neisseria gonorrhoeae and coagglutination has now superseded immunofluorescence in many laboratories.35 Some immunological cross reactions are found between common antigens on N gonorrhoeae and nongonococcal neisseria. Such reactions are not unexpected since the polyclonal antibodies used in the coagglutination reagent, although absorbed to Accepted for publication 8 August 1984 remove non-reacting antibodies, are prepared by immunising rabbits with whole cells of several strains of gonococci. The cross reactions limit the usefulness of coagglutination in identifying isolates from sites such as the throat, where N meningitidis and to a lesser extent N lactamica are the most common isolates,6 and the anorectum of homosexual men, where meningococci are not uncommon.7
Monoclonal antibodies which recognise a single antigenic determinant should facilitate the production of more specific diagnostic reagents. We have evaluated the immunological identification of N gonorrhoeae with coagglutination reagents which employ monoclonal antibodies produced against the major outer membrane protein (protein I) of N gonorrhoeae.8
Material and methods
Clinical isolates of neisseriae were obtained from 1276 
The predictive value of a negative test (PV-) is the probability that the Gram negative diplococci giving a negative coagglutination test are nongonococcal neisseria (or Branhamella) and the formula is:
where p = prevalence of gonococcal Gram negative diplococci within the total population of Gram negative diplococci isolated from a given site, a = test sensitivity, and b = test specificity.
The significance of differences in the results was determined by the X2 test with Yates' correction.
Results Table 1 shows the results of polyclonal and mono- Table 3 . The values of a (sensitivity), b (specificity), and p (prevalence) used in calculating the predictive values given in Table 3 were derived as follows.
The sensitivity and specificity of the monoclonal reagent were 96-6% (198/205) and 98-2% (108/ 110) respectively; these figures represent all clinical isolates tested by the boiled suspension method. The sensitivity and specificity of the polyclonal reagent were 97-4% (406/417) and 96-1% (173/180), respectively. Because of the small number of isolates tested with the polyclonal reagent these are composite results of the present and previous study,5 which gave a sensitivity of 96-7% (318/329) and a specificity of 96-8% (120/124) with the same reagents.
The values of p (the proportion of gonococcal Gram negative diplococci within the total population of Gram negative diplococci from various anatomical sites) as given in Table 3 were taken from the finding that over a 4 year period N gonorrhoeae accounted for 20-3% of 1204 throat isolates of Gram negative diplococci6; and that of the Gram negative diplococci isolated over a 5 year period N gonorrhoeae accounted for 99-6% of 1944 anogenital isolates from women, 99-7% of 2623 urethral isolates from heterosexual men, 95-3% of 384 anogenital isolates, and 92-0% of 225 rectal isolates from homosexual men."
Discusson
The advent of monoclonal antibodies raises the possibility of improved and more widely applied immunological methods of identifying microorganisms. In our "in use" evaluation, however, there was no significant difference in sensitivity and specificity of monoclonal and polyclonal antibody reagents for the routine identification of clinical isolates of N gonorrhoeae.
Although factors such as sensitivity and specificity are important in evaluating new methods, the utility of a test result (the predictive value) depends on the prevalence of gonococcal Gram negative diplococci among the total population of Gram negative diplococci tested. As shown in Table 3 , although the sensitivity and specificity of the test method remain the same, the predictive value varies greatly depending on the anatomical site of isolation. From these results we can make sound recommendations regarding the application of immunological methods for the laboratory identification of N gonorrhoeae.
Clearly, coagglutination testing with either polyclonal or monoclonal reagents may be recommended for the identification of gonococci from an anogenital site, although reliability is less in the case of isolates from homosexual men, when 1 to 3 per 1000 positive tests will be false positives; the corresponding rate with isolates from heterosexual patients is 1 to 2 false positives per 10 000 positive tests. A positive coagglutination result on an isolate from the throat is less reliable than in the case of anogenital isolates; there will be 7 false positives per 100 positive tests with the monoclonal reagent and 14 false positives per 100 positive tests with the polyclonal reagent. Although this difference is not significant at the 5% level with 100 positive results, it becomes significant with 200 positive results.
It should be emphasised, however, that our criteria in assessing these reagents are extremely strict. Of 110 non-gonococcal neisseriae 108 gave unequivocally negative results, giving a specificity of 98-2%. One isolate of N lactamica gave a nonspecific reaction and one strain of N meningitidis gave a positive reaction on first isolation but was negative when tested after two sub-cultures. In calculating the positive predictive value, these two results were included as "positive tests." It is of interest that these two results occurred in the first part of the survey, when we had least experience of the reagents; during the second part of the survey the specificity was 100% (54/54). In a preliminary evaluation of the same monoclonal reagents Philip et al'2 found all 27 isolates of non-gonococcal neisseriae tested gave a negative reaction. Although a larger study is required, we consider that monoclonal coagglutination reagents are likely to achieve a level of specificity such that the predictive value of a positive test result is a reliable indicator of pharyngeal gonorrhoea in patients attending a clinic for sexually transmitted diseases.
Because of the predominance of meningococci in the throat a negative coagglutination result is a reliable indicator of non-gonococcal neisseriae; fewer than one negative result in 100 will be a false negative. Because of the extremely rare occurrence of meningococci in anogenital specimens from heterosexual patients, however, a negative coagglutination result is not a reliable indicator of nongonococcal neisseriae; about 9 of 10 negative results will be false negatives and gonococcal infection could pass undiagnosed. Although meningococci are isolated more frequently from anogenital sites in homosexual men, a negative coagglutination result with these isolates remains unreliable since 2 to 4 of 10 negative results will be false.
Because of its slightly greater sensitivity the negative predictive value of the polyclonal reagent is 1280 marginally better than that of the monoclonal reagent. A sensitivity of 99 99% would be required, however, to give a negative predictive value of 97-5% for an anogenital isolate from a heterosexual patient; a sensitivity of 99 90% would give a negative predictive value of only 79 7%. It will obviously be difficult to achieve a sensitivity greater than 99*90% given that the sensitivity of the monoclonal reagent was 96-6% (198/205) 
